Disentangling prescribing behaviour of Cypriot physicians, within a complex framework of interacting
Author
Abstract
Suggested Citation
DOI: 10.1002/hpm.3480
Download full text from publisher
References listed on IDEAS
- Toshiaki Iizuka, 2012. "Physician Agency and Adoption of Generic Pharmaceuticals," American Economic Review, American Economic Association, vol. 102(6), pages 2826-2858, October.
- Granlund, David, 2009. "Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?," Social Science & Medicine, Elsevier, vol. 69(11), pages 1643-1650, December.
- Prosser, Helen & Walley, Tom, 2006. "New drug prescribing by hospital doctors: The nature and meaning of knowledge," Social Science & Medicine, Elsevier, vol. 62(7), pages 1565-1578, April.
- Wadmann, Sarah & Bang, Lia E., 2015. "Rationalising prescribing: Evidence, marketing and practice-relevant knowledge," Social Science & Medicine, Elsevier, vol. 135(C), pages 109-116.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Janssen, Aljoscha & Granlund, David, 2023. "The importance of the first generic substitution: Evidence from Sweden," Journal of Economic Behavior & Organization, Elsevier, vol. 213(C), pages 1-25.
- Janssen, Aljoscha & Granlund, David, 2022. "The Importance of the First Generic Substitution: Evidence from Sweden," Working Paper Series 1428, Research Institute of Industrial Economics.
- Fiorentini, Gianluca & Bruni, Matteo Lippi & Mammi, Irene, 2022. "The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour," Journal of Economic Behavior & Organization, Elsevier, vol. 204(C), pages 37-68.
- Crea, Giovanni & Galizzi, Matteo M. & Linnosmaa, Ismo & Miraldo, Marisa, 2019.
"Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data,"
Journal of Health Economics, Elsevier, vol. 65(C), pages 153-169.
- Crea, Giovanni & Galizzi, Matteo M. & Linnosmaa, Ismo & Miraldo, Marisa, 2019. "Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data," LSE Research Online Documents on Economics 100301, London School of Economics and Political Science, LSE Library.
- Skipper, Niels & Vejlin, Rune, 2015.
"Determinants of generic vs. brand drug choice: Evidence from population-wide Danish data,"
Social Science & Medicine, Elsevier, vol. 130(C), pages 204-215.
- Niels Skipper & Rune Vejlin, 2013. "Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data," Economics Working Papers 2013-05, Department of Economics and Business Economics, Aarhus University.
- Carolina Lopez & Anja Sautmann & Simone Schaner, 2022.
"Does Patient Demand Contribute to the Overuse of Prescription Drugs?,"
American Economic Journal: Applied Economics, American Economic Association, vol. 14(1), pages 225-260, January.
- Pereira Lopez,Carolina & Sautmann,Anja & Schaner,Simone Gabrielle, 2020. "Does Patient Demand Contribute to the Overuse of Prescription Drugs ?," Policy Research Working Paper Series 9482, The World Bank.
- Ikegami, Kei & Onishi, Ken & Wakamori, Naoki, 2021.
"Competition-driven physician-induced demand,"
Journal of Health Economics, Elsevier, vol. 79(C).
- Kei Ikegami & Ken Onishi & Naoki Wakamori, 2020. "Induced Physician-Induced Demand," CIRJE F-Series CIRJE-F-1149, CIRJE, Faculty of Economics, University of Tokyo.
- Mariana Carrera & Dana Goldman & Geoffrey Joyce, 2013. "Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician," NBER Working Papers 19186, National Bureau of Economic Research, Inc.
- Iizuka, Toshiaki & Nishiyama, Katsuhiko & Chen, Brian & Eggleston, Karen, 2021.
"False alarm? Estimating the marginal value of health signals,"
Journal of Public Economics, Elsevier, vol. 195(C).
- Toshiaki Iizuka & Katsuhiko Nishiyama & Brian Chen & Karen Eggleston, 2017. "False Alarm? Estimating the Marginal Value of Health Signals," NBER Working Papers 23413, National Bureau of Economic Research, Inc.
- Gerald J. Pruckner & Thomas Schober, 2018.
"Hospitals and the generic versus brand‐name prescription decision in the outpatient sector,"
Health Economics, John Wiley & Sons, Ltd., vol. 27(8), pages 1264-1283, August.
- Gerald J. Pruckner & Thomas Schober, 2016. "Hospitals and the generic versus brand-name prescription decision in the outpatient sector," CDL Aging, Health, Labor working papers 2016-05, The Christian Doppler (CD) Laboratory Aging, Health, and the Labor Market, Johannes Kepler University Linz, Austria.
- Gerald J. Pruckner & Thomas Schober, 2016. "Hospitals and the generic versus brand-name prescription decision in the outpatient sector," Economics working papers 2016-11, Department of Economics, Johannes Kepler University Linz, Austria.
- Richards, Michael R. & Seward, Jonathan A. & Whaley, Christopher M., 2022. "Treatment consolidation after vertical integration: Evidence from outpatient procedure markets," Journal of Health Economics, Elsevier, vol. 81(C).
- Shin‐Yi Chou & James A. Dearden & Mary E. Deily & Hsien‐Ming Lien, 2020. "Provider responses to a global budgeting system: The case of drug expenditures in Taiwan hospitals," Health Economics, John Wiley & Sons, Ltd., vol. 29(10), pages 1270-1278, October.
- Müller, Tobias & Schmid, Christian & Gerfin, Michael, 2023.
"Rents for Pills: Financial incentives and physician behavior,"
Journal of Health Economics, Elsevier, vol. 87(C).
- Gerfin, Michael & Müller, Tobias & Schmid, Christian, 2022. "Rents for Pills: Financial Incentives and Physician Behavior," VfS Annual Conference 2022 (Basel): Big Data in Economics 264037, Verein für Socialpolitik / German Economic Association.
- Andrew J. Epstein & Jonathan D. Ketcham, 2014. "Information technology and agency in physicians' prescribing decisions," RAND Journal of Economics, RAND Corporation, vol. 45(2), pages 422-448, June.
- Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
- Victoria Serra-Sastre & Simona Bianchi & Jorge Mestre-Ferrandiz & Phill O’Neill, 2021. "Does NICE influence the adoption and uptake of generics in the UK?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(2), pages 229-242, March.
- Mihajlo B, Jakovljevic & Nakazono, S & Ogura, S, 2014. "Contemporary generic market in Japan – key conditions to successful evolution," CIS Discussion paper series 613, Center for Intergenerational Studies, Institute of Economic Research, Hitotsubashi University.
- Wonsuk Chung & Rick Harbaugh, 2019. "Biased recommendations from biased and unbiased experts," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 28(3), pages 520-540, June.
- David Bardey & Denis Gromb & David Martimort & Jérôme Pouyet, 2020.
"Controlling Sellers Who Provide Advice: Regulation and Competition,"
Journal of Industrial Economics, Wiley Blackwell, vol. 68(3), pages 409-444, September.
- Pouyet, Jérôme & Martimort, David & Gromb, Denis & Bardey, David, 2019. "Controlling Sellers Who Provide Advice: Regulation and Competition," CEPR Discussion Papers 13543, C.E.P.R. Discussion Papers.
- David Bardey & Denis Gromb & David Martimort & Jérôme Pouyet, 2020. "Controlling Sellers Who Provide Advice: Regulation and Competition," Post-Print halshs-02973307, HAL.
- David Bardey & Denis Gromb & David Martimort & Jérôme Pouyet, 2020. "Controlling Sellers Who Provide Advice: Regulation and Competition," PSE-Ecole d'économie de Paris (Postprint) halshs-02973307, HAL.
- Magno, Cielo & Guzman, Ricardo Rafael S., 2019. "Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockers," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 268-279.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:ijhplm:v:37:y:2022:i:4:p:2410-2420. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0749-6753 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.